Celularity Inc. (NASDAQ:CELUW) Sees Significant Increase in Short Interest

Celularity Inc. (NASDAQ:CELUW) was the target of a significant growth in short interest during the month of June. As of June 15th, there was short interest totaling 56,439 shares, a growth of 425.4% from the May 31st total of 10,742 shares. Based on an average trading volume of 24,574 shares, the days-to-cover ratio is presently 2.3 days.

Celularity Trading Down 20.0%

Shares of CELUW stock traded down $0.00 during trading hours on Friday, reaching $0.00. The company’s stock had a trading volume of 1,201 shares, compared to its average volume of 19,526. Celularity has a fifty-two week low of $0.00 and a fifty-two week high of $0.06. The firm’s 50 day simple moving average is $0.01 and its 200-day simple moving average is $0.01.

About Celularity

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.